Position in PHAT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,957,036
+$453,010 QoQ
Shares Held
626,196
+59.7% QoQ
Ownership
0.785%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. PHAT ranks #159 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in PHAT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,957,036 | 626,196 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,504,026 | 392,045 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,789,415 | 152,032 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,846,323 | 192,526 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,177,969 | 187,874 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $3,347,566 | 412,262 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $7,850,715 | 434,221 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,298,025 | 417,284 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,202,290 | 207,372 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,919,225 | 210,211 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $1,436,244 | 138,500 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $2,214,845 | 154,668 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $347,581 | 48,681 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $830,414 | 74,012 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $635,349 | 57,342 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $442,019 | 52,372 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $385,665 | 28,337 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $671,081 | 34,117 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $229,932 | 7,163 | Shares | Defined | 2022-01-20 | |
| 2020-12-31 | $1,464,271 | 44,078 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||